J Neuropathol Exp Neurol. 2007 May;66(5):329-36.

The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.

Source

University of Louisville School of Medicine, Louisville, Kentucky 40202, USA. i.litvan@louisville.edu

Abstract

We are at a critical juncture in our knowledge of the etiology and pathogenesis of Parkinson disease (PD). It is clear that PD is not a single entity simply resulting from a dopaminergic deficit; rather it is most likely caused by a combination of genetic and environmental factors. Although there is extensive new information on the etiology and pathogenesis of PD, which may advance its treatment, new syntheses of this information are needed. The second part of this two-part, state-of-the-art review by leaders in PD research critically examines the research field to identify areas for which new knowledge and ideas might be helpful for treatment purposes. Topics reviewed in Part II are genetics, animal models, and oxidative stress.

PMID:: 17483689; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Grant Support

Publication Types

Review

MeSH Terms

Grant Support

R01 AG024040-01A2/AG/NIA NIH HHS/United States

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Related citations

Review The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. [J Neuropathol Exp Neurol. 2007]
Review The etiopathogenesis of Parkinson disease and suggestions for future research. Part I.
Litvan I, Halliday G, Hallett M, Goetz CG, Rocca W, Duyckaerts C, Ben-Shlomo Y, Dickson DW, Lang AE, Chesselet MF, et al. J Neuropathol Exp Neurol. 2007 Apr; 66(4):251-7.
Review Gene-environment interactions in Parkinson's disease. [Parkinsonism Relat Disord. 2007]
Review Gene-environment interactions in Parkinson's disease.
Ross CA, Smith WW. Parkinsonism Relat Disord. 2007; 13 Suppl 3:S309-15.
Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease. [Regen Med. 2007]
Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease.
Yamashita H, Matsumoto M. Regen Med. 2007 Jul; 2(4):447-55.
Review Parkinson disease: etiology, pathogenesis and future of gene therapy. [Neurosci Res. 2001]
Review Parkinson disease: etiology, pathogenesis and future of gene therapy.
Shastry BS. Neurosci Res. 2001 Sep; 41(1):5-12.
Review Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease. [Neurotoxicology. 2010]
Review Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease.
Kanthasamy A, Jin H, Mehrotra S, Mishra R, Kanthasamy A, Rana A. Neurotoxicology. 2010 Sep; 31(5):555-61. Epub 2009 Dec 11.

See reviews... See all...

Cited by 4 PubMed Central articles

Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with alpha-synuclein genotype. [J Neurochem. 2009]
Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with alpha-synuclein genotype.
Rappley I, Myers DS, Milne SB, Ivanova PT, Lavoie MJ, Brown HA, Selkoe DJ. J Neurochem. 2009 Oct; 111(1):15-25. Epub 2009 Jul 17.
Review Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. [Antioxid Redox Signal. 2009]
Review Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.
Orellana JA, Sáez PJ, Shoji KF, Schalper KA, Palacios-Prado N, Velarde V, Giaume C, Bennett MV, Sáez JC. Antioxid Redox Signal. 2009 Feb; 11(2):369-99.
Review In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease? [Exp Neurol. 2008]
Review In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease?
Chesselet MF. Exp Neurol. 2008 Jan; 209(1):22-7. Epub 2007 Aug 23.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The etiopathogenesis of Parkinson disease and suggestions for future research. P...
The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.
J Neuropathol Exp Neurol. 2007 May ;66(5):329-36.

PubMed
Region-specific sprouting of crossed corticofugal fibers after unilateral cortic...
Region-specific sprouting of crossed corticofugal fibers after unilateral cortical lesions in adult mice.
Exp Neurol. 2006 Feb ;197(2):451-7.

PubMed
Conceptual and methodologic challenges of assessing the short-term efficacy of G...
Conceptual and methodologic challenges of assessing the short-term efficacy of Guggulu in obesity: data emergent from a naturalistic clinical trial.
J Postgrad Med. 1995 Jan-Mar ;41(1):5-7.

PubMed
Surface Energy of Microcrystalline Cellulose Determined by Capillary Intrusion a...
Surface Energy of Microcrystalline Cellulose Determined by Capillary Intrusion and Inverse Gas Chromatography
AAPS J. 2008/09; 10(3): 494-503.

PMC
Menopause, postmenopausal hormone use and serum uric acid levels in US women – T...
Menopause, postmenopausal hormone use and serum uric acid levels in US women – The Third National Health and Nutrition Examination Survey
Arthritis Res Ther. 2008; 10(5): R116.

PMC

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: